LOWER: Lomitapide Observational Worldwide Evaluation Registry (LOWER Trial)
Recruiting in Palo Alto (17 mi)
+43 other locations
Age: Any Age
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Amryt Pharma
No Placebo Group
Trial Summary
What is the purpose of this trial?This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and effectiveness of lomitapide.
Eligibility Criteria
Participant Groups
1Treatment groups
Experimental Treatment
Group I: LomitapideExperimental Treatment1 Intervention
Lomitapide as prescribed by Physician.
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Northside Hospital, Inc.Cumming, GA
Nova Scotia Health AuthorityHalifax, Canada
Stern Cardiovascular FoundationSouthaven, MS
Methodist Physicians ClinicOmaha, NE
More Trial Locations
Loading ...
Who is running the clinical trial?
Amryt PharmaLead Sponsor